Anti-IGF-1 receptor (IGF-1R) monoclonal antibodies (mAbs) were developed for clinical use in treating advanced stage cancers 22,23,24 , including Ganitumab, which remains under investigation as a combination therapy in clinical trials targeting Rhabdomyosarcoma (NCT03041701) and Ewing Sarcoma (NCT02306161), for which it recently received orphan drug status
Muscle Cell Growth Medium (Cat# CC-3245, Lonza)
EASL clinical practice guidelines: Drug-induced liver injury
Every batch of LiveWell IGF-1 LR3 is third-party tested and ships with a Certificate of Analysis (COA), typically 99%+ purity by HPLC
Li Q, Wu S, Li SY, Lopez FL, Du M, Kajstura J, Anversa P, Ren J: Cardiac-specific overexpression of insulin-like growth factor 1 attenuates aging-associated cardiac diastolic contractile dysfunction and protein damage